PRODUCT LITERATURE

Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real‐world patients: A nationwide study

---

Allopurinol carries a well‐known risk of cutaneous adverse reactions (CARs). Although febuxostat, a xanthine‐oxidase inhibitor with different chemical structure, has been considered an alternative to allopurinol, post‐marketing case reports of life‐ threatening febuxostat‐related CARs have been reported. We aimed to compare the risk of CARs between allopurinol and febuxostat in real‐world settings and to assess the impact of the market entry of febuxostat on allopurinol use and associated CARs.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Festaric
Febuxostat
Allopurinol

Specific Detail Info

Int J Clin Pract. 2019;73:e13316

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment